Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Eli Lilly & Co., consolidated balance sheet: assets (quarterly data)

US$ in thousands

	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cash and cash equivalents	9,791,900)	3,375,900)	3,093,300)	3,268,400)	3,369,000)	3,223,600)	2,460,200)	2,818,600)	2,380,800)	2,694,500)	3,545,900)	2,067,000)	2,617,400)	2,622,900)	2,459,200)	3,818,500)	3,788,200)	3,220,000)	3,002,400)	3,657,100)	3,595,300)	2,365,100)	1,699,000)
Short-term investments	121,600)	170,100)	127,400)	154,800)	149,400)	140,400)	126,100)	109,100)	113,100)	134,600)	123,400)	144,800)	124,700)	113,800)	109,100)	90,100)	37,100)	51,200)	49,000)	24,200)	35,000)	22,800)	78,400)
Accounts receivable, net of allowances	16,107,400)	14,170,400)	12,036,600)	11,005,700)	10,294,800)	11,027,900)	7,885,600)	9,090,500)	8,167,100)	7,516,100)	7,526,200)	6,896,000)	6,715,300)	6,364,500)	6,322,500)	6,672,800)	5,914,300)	5,829,400)	5,592,800)	5,875,300)	4,886,700)	4,828,900)	5,106,100)
Other receivables	3,349,800)	3,035,200)	1,966,600)	2,269,700)	1,756,900)	2,051,100)	2,127,900)	2,245,700)	2,196,700)	1,655,300)	1,495,900)	1,662,900)	1,609,500)	1,307,900)	1,483,200)	1,454,400)	1,110,700)	1,073,400)	1,065,800)	1,053,700)	958,100)	946,700)	1,246,400)
Inventories	12,180,400)	11,013,800)	9,311,000)	7,589,200)	7,459,800)	6,481,500)	6,101,800)	5,772,800)	4,901,400)	4,798,700)	4,544,800)	4,309,700)	3,831,100)	3,899,400)	3,893,000)	3,886,000)	3,907,400)	3,824,900)	3,660,800)	3,980,300)	3,555,400)	3,313,900)	3,102,400)
Prepaid expenses	20,248,700)	18,019,800)	14,653,900)	8,340,500)	8,250,600)	7,137,600)	6,348,600)	5,540,800)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Other current assets	271,500)	68,800)	72,400)	111,400)	134,600)	142,200)	138,600)	149,500)	5,247,900)	4,532,400)	3,575,200)	2,954,100)	2,741,900)	2,806,700)	2,697,700)	2,530,600)	3,050,600)	3,296,600)	3,233,700)	2,871,500)	3,209,400)	3,104,500)	2,761,900)
Current assets	62,071,300)	49,854,000)	41,261,200)	32,739,700)	31,415,100)	30,204,300)	25,188,800)	25,727,000)	23,007,000)	21,331,600)	20,811,400)	18,034,500)	17,639,900)	17,115,200)	16,964,700)	18,452,400)	17,808,300)	17,295,500)	16,604,500)	17,462,100)	16,239,900)	14,581,900)	13,994,200)
Investments	2,808,300)	3,207,400)	3,222,700)	3,215,900)	3,200,200)	2,877,600)	3,086,900)	3,052,200)	2,691,700)	2,745,100)	2,750,400)	2,901,800)	2,574,600)	2,587,200)	2,727,300)	3,212,600)	3,350,500)	3,474,900)	3,232,400)	2,966,800)	2,476,200)	2,406,400)	2,148,700)
Goodwill	5,898,000)	5,770,500)	5,770,500)	5,770,300)	5,768,400)	5,768,200)	4,939,600)	4,939,700)	4,085,200)	4,078,900)	4,073,100)	4,073,000)	3,891,600)	3,891,800)	3,892,000)	3,892,000)	3,884,100)	3,884,200)	3,877,400)	3,766,500)	3,726,400)	3,723,200)	3,779,100)
Other intangibles, net	6,446,700)	5,908,300)	6,012,200)	6,166,300)	6,537,300)	6,636,100)	6,762,200)	6,906,600)	6,781,700)	6,903,500)	7,087,100)	7,206,600)	7,124,100)	7,497,700)	7,482,400)	7,691,900)	7,887,700)	7,985,400)	8,087,800)	7,450,000)	7,588,600)	7,712,500)	7,766,700)
Deferred tax assets	8,962,700)	9,427,400)	8,573,200)	8,000,600)	7,392,300)	6,655,300)	5,633,900)	5,477,300)	4,574,800)	3,805,900)	3,406,700)	2,792,900)	2,384,300)	2,371,900)	2,464,900)	2,489,300)	2,625,600)	2,674,900)	2,649,900)	2,830,400)	2,555,300)	2,481,800)	2,471,600)
Property and equipment, net of accumulated depreciation	22,316,000)	20,529,700)	18,474,100)	17,102,400)	16,171,800)	14,829,400)	13,624,000)	12,913,600)	11,863,200)	11,277,400)	10,546,200)	10,144,000)	9,311,300)	9,128,200)	9,102,700)	8,985,100)	8,920,400)	8,855,500)	8,630,100)	8,681,900)	8,281,100)	7,981,100)	7,897,900)
Other noncurrent assets	6,432,400)	6,225,300)	6,074,900)	5,719,700)	5,121,800)	4,903,900)	4,708,100)	4,989,900)	4,911,900)	4,671,600)	4,488,100)	4,337,000)	4,535,700)	4,471,600)	4,285,300)	4,082,700)	3,710,400)	3,638,600)	3,756,200)	3,475,400)	3,078,500)	3,080,100)	3,044,600)
Noncurrent assets	52,864,100)	51,068,600)	48,127,600)	45,975,200)	44,191,800)	41,670,500)	38,754,700)	38,279,300)	34,908,500)	33,482,400)	32,351,600)	31,455,300)	29,821,600)	29,948,400)	29,954,600)	30,353,600)	30,378,700)	30,513,500)	30,233,800)	29,171,000)	27,706,100)	27,385,100)	27,108,600)
Total assets	114,935,400)	100,922,600)	89,388,800)	78,714,900)	75,606,900)	71,874,800)	63,943,500)	64,006,300)	57,915,500)	54,814,000)	53,163,000)	49,489,800)	47,461,500)	47,063,600)	46,919,300)	48,806,000)	48,187,000)	47,809,000)	46,838,300)	46,633,100)	43,946,000)	41,967,000)	41,102,800)

Cash and Cash Equivalents: The cash and cash equivalents showed notable fluctuations throughout the periods. Starting at 1.7 billion USD in early 2020, it peaked significantly towards the end of the forecast period, reaching nearly 9.8 billion USD by the third quarter of 2025. This upward trend from 2023 onwards suggests an enhanced liquidity position or possibly proceeds from financing or divestitures.
Short-term Investments: Short-term investments remained relatively stable with minor fluctuations between approximately 22,800 USD and 170,100 USD, showing no strong upward or downward trend. This stability implies a consistent approach to managing liquid investments without significant expansion or reduction.
Accounts Receivable, Net: Accounts receivable exhibited a steady increase over the entire period, rising from about 5.1 billion USD in early 2020 to over 16.1 billion USD in late 2025. This upward trajectory reflects consistent revenue generation with potentially extended credit terms or increased sales volume.
Other Receivables: Other receivables displayed variability but generally trended upward, starting at 1.25 billion USD and ending at approximately 3.3 billion USD. This increase might indicate growth in other forms of receivables, possibly related to royalties, reimbursements, or other operating assets.
Inventories: Inventory levels increased progressively from approximately 3.1 billion USD to around 12.2 billion USD, with marked acceleration starting in 2023. This sharp rise could indicate stockpiling in anticipation of higher demand, new product launches, or supply chain considerations.
Prepaid Expenses: Prepaid expenses data is only available from 2023 forward, with a substantial increase from about 5.5 billion USD to over 20.2 billion USD by the end of 2025. This considerable growth suggests increased advance payments which may be related to contractual commitments, insurance, or marketing expenditures.
Other Current Assets: Other current assets showed some fluctuation but decreased significantly between late 2023 and late 2025, dropping from approximately 3.5 billion USD to below 300 million USD before modest improvement towards the end. This volatility may reflect adjustments in miscellaneous current asset accounts or potential reclassifications.
Current Assets: Overall current assets grew substantially, rising from about 14 billion USD in early 2020 to over 62 billion USD by late 2025. The composition changes, especially the surge in prepaid expenses and cash equivalents, illustrate a more liquid and asset-rich current position over time.
Investments: Investments remained relatively stable, fluctuating between approximately 2.2 billion and 3.2 billion USD, without a definite trend, indicating a steady portfolio size.
Goodwill: Goodwill increased moderately from 3.7 billion USD at the start to nearly 5.9 billion USD by the end of the period. Such growth is typically linked to acquisitions or business combinations, reflecting business expansion efforts.
Other Intangibles, Net: Other intangibles decreased gradually from about 7.8 billion USD to near 6.4 billion USD, signaling amortization or impairment over time, partially offset by some fluctuations later in the timeline.
Deferred Tax Assets: Deferred tax assets rose steadily from around 2.5 billion USD to nearly 9 billion USD, reflecting increasing temporary differences or tax loss carryforwards, which could impact future tax liabilities positively.
Property and Equipment, Net: Property and equipment increased consistently, from nearly 7.9 billion USD to over 22.3 billion USD. This sustained investment indicates capital expenditure growth, likely tied to facility expansion, equipment acquisition, or upgrades.
Other Noncurrent Assets: Other noncurrent assets showed a generally upward trend with mild fluctuations, growing from about 3 billion USD to more than 6.4 billion USD, suggesting accumulations in various long-term holdings or deferred charges.
Noncurrent Assets: The total noncurrent assets displayed steady growth, increasing from approximately 27.1 billion USD to nearly 53 billion USD. This reflects ongoing investments in tangible and intangible long-term assets, supporting the company's operational capacity and strategic positioning.
Total Assets: Total assets grew significantly from around 41.1 billion USD at the beginning of 2020 to nearly 115 billion USD by late 2025. This substantial increase is driven by growth in both current and noncurrent asset bases, highlighting expansion and increased capitalization.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

Eli Lilly & Co. (NYSE:LLY)

Balance Sheet: Assets Quarterly Data

Assets: Selected Items

Current Assets: Selected Items

Balance Sheet: Assets
Quarterly Data